Cambridge, MA — 

Synlogic has collaborated with Jim Collins and Tim Lu, pioneers in synthetic biology, to develop a platform for the design and advancement of therapeutic microbes.  These microbes can function in a range of ways to treat diseases not easily addressable by systemically delivered, traditional therapies.  In addition, the microbes can adjust their activity based on environmental signals to deliver the right level of response where and when needed.